Loading clinical trials...
Loading clinical trials...
To evaluate the locoregional control, survival rate, toxicity, and quality of life in patients with nasopharyngeal carcinoma treated with reduced prophylactic irradiation doses to the Low-Risk Clinica...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Sun Yat-sen University
Collaborators
NCT05910827 · Advanced or Metastatic Squamous Non-Small Cell Lung Cancer, Advanced Head and Neck Squamous Cell Carcinoma, and more
NCT07376603 · Nasopharyngeal Cancinoma (NPC), Intensity-modulated Radiotherapy, and more
NCT07067268 · Nasopharyngeal Cancinoma (NPC)
NCT06676722 · Nasopharyngeal Cancinoma (NPC), SBRT, and more
NCT06749899 · Nasopharyngeal Cancinoma (NPC), Nasopharyngeal Cancer
Sun yat-sen university cancer center
Guangzhou, Guangdong
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions